ArticleBMC cancer2021

The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocol.

Stephan Ursprung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.